Glaucoma Treatment Market Report

Global and Region Glaucoma Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：210
  • REPORT CODE：GMM1008079
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract.

    The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.

    The report details the trend, potential and market size of Glaucoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Glaucoma Treatmentmarket, defines the market attractiveness level of Glaucoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Glaucoma Treatment industry, describes the types of Glaucoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glaucoma Treatment market and the development prospects and opportunities of Glaucoma Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glaucoma Treatment market in Chapter 13.

    By Player:

    • Novartis

    • Ellex

    • Amorphex Therapeutics

    • Quantel

    • Lumenis

    • Lightmed

    • Icon Bioscience

    • Allergan

    • Ocular Therapeutix

    • Merck

    • Pfizer

    By Type:

    • Prostaglandin Analogs (PGAs),

    • Alpha Agonist

    • Beta Blockers

    • Cholinergic Drugs

    • Carbonic Anhydrase Inhibitors

    • Others

    By End-User:

    • Hospitals

    • Home Users

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Glaucoma Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Glaucoma Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Glaucoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Glaucoma Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Glaucoma Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Glaucoma Treatment Consumption (2017-2022)

    • 7.2 United States Glaucoma Treatment Consumption (2017-2022)

    • 7.3 Europe Glaucoma Treatment Consumption (2017-2022)

    • 7.4 China Glaucoma Treatment Consumption (2017-2022)

    • 7.5 Japan Glaucoma Treatment Consumption (2017-2022)

    • 7.6 India Glaucoma Treatment Consumption (2017-2022)

    • 7.7 South Korea Glaucoma Treatment Consumption (2017-2022)

    8 Region and Country-wise Glaucoma Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.4 China Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.6 India Glaucoma Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Glaucoma Treatment Consumption Forecast (2022-2028)

    9 Global Glaucoma Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Glaucoma Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prostaglandin Analogs (PGAs), Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Alpha Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Beta Blockers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Cholinergic Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Carbonic Anhydrase Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Glaucoma Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Home Users Consumption and Growth Rate (2017-2022)

    10 Global Glaucoma Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Glaucoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Prostaglandin Analogs (PGAs), Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Alpha Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Cholinergic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Carbonic Anhydrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Glaucoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Home Users Consumption Forecast and Growth Rate (2022-2028)

    11 Global Glaucoma Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Glaucoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Glaucoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Glaucoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Glaucoma Treatment Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Glaucoma Treatment Product and Service

    • 14.2 Ellex

      • 14.2.1 Ellex Company Details

      • 14.2.2 Ellex Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Ellex Glaucoma Treatment Product and Service

    • 14.3 Amorphex Therapeutics

      • 14.3.1 Amorphex Therapeutics Company Details

      • 14.3.2 Amorphex Therapeutics Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amorphex Therapeutics Glaucoma Treatment Product and Service

    • 14.4 Quantel

      • 14.4.1 Quantel Company Details

      • 14.4.2 Quantel Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Quantel Glaucoma Treatment Product and Service

    • 14.5 Lumenis

      • 14.5.1 Lumenis Company Details

      • 14.5.2 Lumenis Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Lumenis Glaucoma Treatment Product and Service

    • 14.6 Lightmed

      • 14.6.1 Lightmed Company Details

      • 14.6.2 Lightmed Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Lightmed Glaucoma Treatment Product and Service

    • 14.7 Icon Bioscience

      • 14.7.1 Icon Bioscience Company Details

      • 14.7.2 Icon Bioscience Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Icon Bioscience Glaucoma Treatment Product and Service

    • 14.8 Allergan

      • 14.8.1 Allergan Company Details

      • 14.8.2 Allergan Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Allergan Glaucoma Treatment Product and Service

    • 14.9 Ocular Therapeutix

      • 14.9.1 Ocular Therapeutix Company Details

      • 14.9.2 Ocular Therapeutix Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ocular Therapeutix Glaucoma Treatment Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Glaucoma Treatment Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Glaucoma Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Glaucoma Treatment

    • Figure Glaucoma Treatment Picture

    • Table Global Glaucoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glaucoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glaucoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Glaucoma Treatment Consumption by Country (2017-2022)

    • Figure United States Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Glaucoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Glaucoma Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Glaucoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostaglandin Analogs (PGAs), Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Beta Blockers Consumption and Growth Rate (2017-2022)

    • Figure Global Cholinergic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Carbonic Anhydrase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Home Users Consumption and Growth Rate (2017-2022)

    • Figure Global Prostaglandin Analogs (PGAs), Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alpha Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholinergic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carbonic Anhydrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Users Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Glaucoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Glaucoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Glaucoma Treatment Product and Service

    • Table Ellex (Foundation Year, Company Profile and etc.)

    • Table Ellex Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ellex Glaucoma Treatment Product and Service

    • Table Amorphex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Amorphex Therapeutics Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amorphex Therapeutics Glaucoma Treatment Product and Service

    • Table Quantel (Foundation Year, Company Profile and etc.)

    • Table Quantel Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quantel Glaucoma Treatment Product and Service

    • Table Lumenis (Foundation Year, Company Profile and etc.)

    • Table Lumenis Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lumenis Glaucoma Treatment Product and Service

    • Table Lightmed (Foundation Year, Company Profile and etc.)

    • Table Lightmed Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lightmed Glaucoma Treatment Product and Service

    • Table Icon Bioscience (Foundation Year, Company Profile and etc.)

    • Table Icon Bioscience Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Icon Bioscience Glaucoma Treatment Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Glaucoma Treatment Product and Service

    • Table Ocular Therapeutix (Foundation Year, Company Profile and etc.)

    • Table Ocular Therapeutix Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ocular Therapeutix Glaucoma Treatment Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Glaucoma Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Glaucoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Glaucoma Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US